175 related articles for article (PubMed ID: 25248094)
21. High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.
Moore AM; Moshkin O; Swain GJ; Crocker S; LeBrun DP
Diagn Pathol; 2018 May; 13(1):34. PubMed ID: 29793519
[TBL] [Abstract][Full Text] [Related]
22.
Tourneret A; Alame M; Rigau V; Bauchet L; Fabbro M; De Oliveira L; Cacheux V; Costes V; Lacheretz-Szablewski V
J Clin Pathol; 2021 Oct; 74(10):650-656. PubMed ID: 32912960
[TBL] [Abstract][Full Text] [Related]
23. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
[TBL] [Abstract][Full Text] [Related]
24. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
25. Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.
Caponetti GC; Dave BJ; Perry AM; Smith LM; Jain S; Meyer PN; Bast M; Bierman PJ; Bociek RG; Vose JM; Armitage JO; Aoun P; Fu K; Greiner TC; Chan WC; Sanger WG; Weisenburger DD
Leuk Lymphoma; 2015; 56(11):3082-9. PubMed ID: 25827211
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
27. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
28. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
[TBL] [Abstract][Full Text] [Related]
29. Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies.
Caraway NP; Du Y; Zhang HZ; Hayes K; Glassman AB; Katz RL
Cancer; 2000 Apr; 90(2):126-32. PubMed ID: 10794162
[TBL] [Abstract][Full Text] [Related]
30. Whole-exome and whole-genome sequencing in chronic lymphocytic leukemia: new biomarkers to target.
Hobeika C; Rached G; Chebly A; Chouery E; Kourie HR
Pharmacogenomics; 2020 Aug; 21(13):957-962. PubMed ID: 32799640
[TBL] [Abstract][Full Text] [Related]
31. Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.
Shustik J; Han G; Farinha P; Johnson NA; Ben Neriah S; Connors JM; Sehn LH; Horsman DE; Gascoyne RD; Steidl C
Haematologica; 2010 Jan; 95(1):96-101. PubMed ID: 19797725
[TBL] [Abstract][Full Text] [Related]
32. Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases.
Wiesner T; Streubel B; Huber D; Kerl H; Chott A; Cerroni L
Am J Surg Pathol; 2005 May; 29(5):666-73. PubMed ID: 15832092
[TBL] [Abstract][Full Text] [Related]
33. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
34. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
Hori Y; Yamamoto H; Nozaki Y; Torisu T; Fujiwara M; Taguchi K; Nishiyama K; Nakamura S; Kitazono T; Oda Y
Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for Richter syndrome in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Curr Hematol Malig Rep; 2014 Sep; 9(3):294-9. PubMed ID: 25218362
[TBL] [Abstract][Full Text] [Related]
36. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
[TBL] [Abstract][Full Text] [Related]
37. BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients.
Akay OM; Aras BD; Isiksoy S; Toprak C; Mutlu FS; Artan S; Oner U; Gulbas Z
Cancer Genet; 2014 Mar; 207(3):87-93. PubMed ID: 24674866
[TBL] [Abstract][Full Text] [Related]
38. Richter transformation with c-MYC overexpression: report of three cases.
Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
[TBL] [Abstract][Full Text] [Related]
39. CD5- and CD23-positive splenic diffuse large B-cell lymphoma with very low CD20 expression.
Tabata R; Iwama H; Tabata C; Yasumizu R; Kojima M
J Clin Exp Hematop; 2014; 54(2):155-61. PubMed ID: 25318949
[TBL] [Abstract][Full Text] [Related]
40. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
